Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Drug stocks climb; Medivation sinks on drug study
Marketwatch
Wednesday, March 3, 2010 - 11:56am
tags:
Medivation, dimebon, drug stocks, Pfizer
Pfizer Said to Set Sights on German Drug Maker
NY Times, NY
Wednesday, March 3, 2010 - 11:55am
tags:
Pfizer, generics, Ratiopharm, Teva Pharmaceuticals, Actavis, M&A
Lessons From Mead Johnson's IPO Stock Spin-Off
Seeking Alpha
Wednesday, March 3, 2010 - 11:54am
tags:
Mead Johnson, Bristol-Myers Squibb, IPOs
Lower Q4 Loss for Human Genome
Yahoo/Zacks.com
Wednesday, March 3, 2010 - 11:52am
tags:
Human Genome Sciences, earnings
Bristol-Myers, Allergan in $413M pain drug deal
Yahoo/AP
Wednesday, March 3, 2010 - 11:51am
tags:
Bristol-Myers Squibb, Allergan, partnerships
NicOx Sells Eye Treatment Rights to Bausch & Lomb
Bloomberg
Wednesday, March 3, 2010 - 11:44am
tags:
NicOx, Bausch & Lomb, glaucoma
Pfizer, Medivation’s Drug Fails in Alzheimer’s Study
Bloomberg
Wednesday, March 3, 2010 - 11:43am
tags:
Pfizer, Medivation, dimebon, Alzheimer's disease
Transition Therapeutics and Lilly in diabetes deal
Yahoo/AP
Wednesday, March 3, 2010 - 11:42am
tags:
Transition Therapeutics, partnerships, Eli Lilly, diabetes
Pfizer's Newly Approved Vaccine Should Be Huge Growth Driver
Seeking Alpha
Wednesday, March 3, 2010 - 11:40am
tags:
Pfizer, vaccines, Prevnar 13
AstraZeneca Starts to Slash
Seeking Alpha
Wednesday, March 3, 2010 - 11:18am
tags:
AstraZeneca
Merck cites positive study results on allergy drug
Yahoo/AP
Wednesday, March 3, 2010 - 11:17am
tags:
Merck, allergies, immunotherapy, Phleum Pratense
Ratiopharm sale in final stages
FT.com
Wednesday, March 3, 2010 - 11:16am
tags:
Ratiopharm, M&A, Teva Pharmaceuticals, Actavis, Pfizer
Bristol-Myers CEO to retire; CFO to succeed him
Yahoo/AP
Tuesday, March 2, 2010 - 4:34pm
tags:
Pharma CEOs, Bristol-Myers Squibb
No Panel For Provenge
Forbes
Tuesday, March 2, 2010 - 2:14pm
tags:
Dendreon, Provenge, FDA
Teva regains exclusivity on blood pressure drugs
Yahoo/AP
Tuesday, March 2, 2010 - 2:12pm
tags:
Teva Pharmaceuticals, antihypertensives, generics, Cozaar, Hyzaar
AZ pitches social-media rules to FDA
Fierce Pharma
Tuesday, March 2, 2010 - 2:10pm
tags:
AstraZeneca, social media, FDA
AstraZeneca shuffles, eliminates Del. R&D jobs
Yahoo/AP
Tuesday, March 2, 2010 - 2:07pm
tags:
R&D, layoffs, reorganization
Controlling Astellas's M&A Urges
WSJ Online
Tuesday, March 2, 2010 - 11:11am
tags:
M&A, Astellas, OSI Pharmaceuticals
Covidien to expand sales force thanks to FDA drug approval
Bizjournals.com
Tuesday, March 2, 2010 - 11:10am
tags:
hirings, sales force, Covidien, FDA, Exalgo
Covidien, CombinatoRx painkiller Exalgo gets FDA nod
Reuters
Tuesday, March 2, 2010 - 11:06am
tags:
Covidien, CombinatoRx, Exalgo, painkillers, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.